Boehringer Ingelheim has over 90 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.
It's Feel Good Friday!
Don't let your asthma get in the way of your time to relax. Show us how you are taking a moment to yourself and share a pic/vid of you relaxing despite asthma to enter our Instagram competition for a chance to win 200 euros worth of Apple vouchers. Follow @thinkactbreathe and see our Instagram profile for how to enter.